Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,015.00    -10.00 (-0.17%)
Bid:
6,005.00
Ask:
6,010.00
Spread: 5.00 (0.083%)
Market Cap: £5.14b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Q3 Trading Statement

5 Feb 2025 07:00

RNS Number : 9079V
DCC PLC
05 February 2025
 

5 February 2025

Q3 Trading Statement

DCC plc, the leading international sales, marketing and support services group, is issuing this Trading Statement for the third quarter ended 31 December 2024.

Robust performance in third quarter

Group adjusted operating profit for the third quarter ended 31 December 2024 was broadly in line with prior year and modestly ahead of the prior year on a constant currency basis.

DCC Energy traded robustly and delivered good operating profit growth. Despite the impact of warmer weather conditions, Energy Solutions delivered good growth driven by the performance of Continental Europe. The Mobility business also performed well and delivered strong growth. DCC Healthcare performed in line with expectations and prior year. Operating profit declined in DCC Technology, driven by a weak market for consumer technology products in the UK and Europe over the holiday season.

Outlook

Notwithstanding the headwind of currency translation, DCC continues to expect that the year ending 31 March 2025 will be a year of good operating profit growth and significant strategic progress.

Strategy and development update

On 12 November 2024, DCC announced an update to the Group's strategy; focusing the Group on the energy sector, simplifying the Group's operations and maximising shareholder value. As outlined in the update, the Group intends to dispose of DCC Healthcare in 2025. The disposal process is progressing in line with expectations.

The Group remains active from a development perspective and has a good pipeline of acquisition opportunities in the energy sector.

Date for Final Results

DCC expects to announce its results for the year ending 31 March 2025 on Tuesday 13 May 2025.

Contact information

Investor enquiries:

Kevin Lucey, Chief Financial Officer

Tel: +353 1 2799 400

Rossa White, Head of Group Investor Relations & Comms

Email: investorrelations@dcc.ie

Media enquiries:

Sodali & Co (Eavan Gannon/Pete Lambie)

Tel: +44 20 7250 1446

Email: DCCGroup@sodali.com

About DCC plc

DCC is a leading international sales, marketing and support services group. We provide solutions the world needs across three transformative sectors: energy, healthcare and technology; where we acquire, improve and grow diverse businesses. We bring our growth mindset to our businesses in 21 countries across four continents, empowering our 16,700 employees to create long term value - for our shareholders, customers, society and the planet.

 

Headquartered in Dublin, DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100. In our financial year ended 31 March 2024, DCC generated revenues of £19.9 billion and adjusted operating profit of £682.8 million. DCC has an excellent record, delivering compound annual growth of 14% in adjusted operating profit and unbroken dividend growth of 13% while maintaining high returns on capital employed over 30 years as a public company.

 

Follow us on LinkedIn

www.dcc.ie

Forward-looking statements

This announcement contains some forward-looking statements that represent DCC's expectations for its business, based on current expectations about future events, which by their nature involve risk and uncertainty. DCC believes that its expectations and assumptions with respect to these forward-looking statements are reasonable, however because they involve risk and uncertainty as to future circumstances, which are in many cases beyond DCC's control, actual results or performance may differ materially from those expressed in or implied by such forward-looking statements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZGGZNDLGKZM
Date   Source Headline
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20255:20 pmRNSTotal Voting Rights
30th May 20255:00 pmRNSDirector/PDMR Shareholding
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSLaunch of £100 million Share Buyback Programme
23rd May 20255:10 pmRNSDirector/PDMR Shareholding
13th May 20257:00 amRNSResults for the year ended 31 March 2025
22nd Apr 20257:00 amRNSDisposal of DCC Healthcare
9th Apr 20257:00 amRNSDCC Leadership Changes
28th Feb 202511:00 amRNSTotal Voting Rights
5th Feb 20257:00 amRNSQ3 Trading Statement
9th Dec 202412:23 pmRNSDirector Declaration
29th Nov 20242:33 pmRNSTotal Voting Rights
18th Nov 20245:30 pmRNSDirector/PDMR Shareholding
12th Nov 20247:01 amRNSResults for the six months ended 30 September 2024
12th Nov 20247:00 amRNSStrategy Update: DCC to focus on Energy sector
20th Aug 20245:52 pmRNSHolding in Company TR-1
31st Jul 20242:20 pmRNSTotal Voting Rights
11th Jul 20244:53 pmRNSResult of AGM
11th Jul 20247:02 amRNSBoard Appointment
11th Jul 20247:01 amRNSDivestment of Hong Kong Energy Business
11th Jul 20247:00 amRNSAGM Trading Statement
12th Jun 202410:09 amRNS2024 Sustainability Report
12th Jun 202410:05 amRNS2024 Annual Report, Notice of AGM and Proxy Form
31st May 20245:00 pmRNSDirector/PDMR Shareholding
31st May 20244:30 pmRNSTotal Voting Rights
24th May 20245:00 pmRNSDirector/PDMR Shareholding
14th May 20247:00 amRNSResults for the year ended 31 March 2024
6th Mar 20244:52 pmRNSHolding in Company
28th Feb 20243:52 pmRNSTotal Voting Rights
7th Feb 20247:00 amRNSInterim Management Statement
31st Jan 20249:44 amRNSTotal Voting Rights
14th Dec 20237:00 amRNSBoard and Remuneration Committee Changes
30th Nov 202311:59 amRNSTotal Voting Rights
24th Nov 20235:34 pmRNSDirector/PDMR Shareholding
20th Nov 20235:45 pmRNSDirector/PDMR Shareholding
14th Nov 20237:01 amRNSAcquisition of Progas GmbH
14th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
6th Sep 20237:00 amRNSDCC Energy Insights Day and Five New Acquisitions
31st Jul 20231:03 pmRNSTotal Voting Rights
13th Jul 20235:22 pmRNSResult of AGM
13th Jul 20237:00 amRNSAGM Trading Statement
14th Jun 202310:09 amRNS2023 Sustainability Report
14th Jun 202310:05 amRNS2023 Annual Report, Notice of AGM and Proxy Form
31st May 20234:38 pmRNSTotal Voting Rights
26th May 20234:58 pmRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSResults for the year ended 31 March 2023
9th May 20237:00 amRNSStatement regarding Chief Executive

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.